While PV is almost exclusively based on a JAK2 driver mutation, ET and PMF also show mutations of calreticulin (CALR) and of the thrombopoietin receptor gene (MPL), with some triple-negative cases (Swerdlow et al., 2017). Here, CALR is linked to acquired polycythemia vera.